T3 · Product exporter position

Japan exports of Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions (HS 300212)

See where Japan stands in blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions: export scale, destination breadth, market position, growth, and reported trade history.

Exporter JPNHS6 300212Latest year 2024Stable

Latest exports

$117.5MLatest observed lane total

Destination markets

89Reported active markets

Three-year growth

+1.3%Annualized change

Destination HHI

2,358Destination concentration

Weighted share

6.8%Reported market position

Exporter evidence

How strong is Japan in Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions?

Reported exporter totals and calculated indicators for HS 300212. Values retain their observed coverage period.

Exporter scale

Latest exports$117.5M
Current 2024 exports$108.8M
Three-year average$120.2M
Historical peak$267.2M

Market position

Active destinations89
Destination HHI2,358
Weighted share6.8%
Share change+0.1 pp

Competitiveness

Three-year growth+1.3%
Volatility0.9
Maximum drawdown45.6%
TrendStable
MeasureValueWhat it describes
ExporterJapanCountry represented by this profile
Latest observed exports$117.5MSum of latest observed destination-lane values
Current 2024 exports$108.8MCommon-year comparison where reported
Three-year growth+1.3%Annualized change in exporter totals
Five-year growth+2.7%Annualized change in exporter totals
Leading destinationUSADestination with the largest observed export value
Leading destination share41.9%Share of observed exporter totals
Destination concentration2,358HHI across destination markets
Weighted share change+0.1 ppValue-weighted latest change in market share
Limited-history lanes14.3%Share of lanes with shorter history

Destination markets

Where does Japan sell blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions?

Leading destination observations ranked by reported export value, with market position and access context.

Destination observations are not available.

Price intelligence

How does Japan's price position vary?

Price comparisons are shown where market-level unit-value observations are available. They describe reported trade values and quantities, not quoted selling prices.

Highest reported price

Switzerland, Liechtenstein: $486.5M / ton.

Lowest reported price

United Rep. of Tanzania: $1.9K / ton.

Median price

$340.0K / ton across reported markets.

Export trend

Reported export history

Annual observations for Japan and HS 300212 where available.

YearExportsYear-on-year changeActive destinations
2012$38.1MNot reported123
2013$48.0M+26.2%124
2014$48.1M+0.1%124
2015$51.2M+6.4%123
2016$74.2M+44.9%130
2017$130.1M+75.4%117
2018$106.1M-18.5%105
2019$95.4M-10%102
2020$82.8M-13.3%99
2021$104.7M+26.5%94
2022$145.2M+38.7%95
2023$106.6M-26.6%92
2024$108.8M+2%89

Exporter context

Japan economy and trade network

The exporter profile adds country-level trade and structural context to the selected product position. These indicators describe the country overall and are not limited to HS 300212.

Japan has reported exports of $740.4B and a trade balance of $48.6B in 2024.

Available structural indicators include 20% trade openness, 24.8% investment, and 270 active trade partners.

Reported values

Export totals and destination values describe reported merchandise trade for the stated exporter, HS6 classification, and available year.

Calculated indicators

Growth, concentration, weighted share, volatility, drawdown, and price comparisons are calculated from reported observations.

Coverage

Missing values remain “Not reported”. Country-level indicators are presented separately from product-level observations.

Frequently asked questions

Questions about Japan blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions exports

Quick answers based on the figures and coverage shown on this page.

How strong is this exporter?

Use latest exports, destination breadth, growth, concentration, and weighted share together rather than relying on one measure.

Which markets are most important?

The destination table ranks reported markets by the latest observed export value.

Does the price section show quotes?

No. It summarizes reported trade value and quantity observations converted to unit values.

What should be checked next?

Compare this exporter with buyer markets, corridors, and the product overview before making a commercial decision.